Challenges in diagnosis and treatment of cystinuria patients with Urolithiasis: multicenter patient centered study. Original Story Cystinuria represents a rare cause of urolithiasis, accounting for 1% of all cases. However, it poses unique challenges in diagnosis and management. This study aimed to examine the challenges of managing cystine stones from the perspective of cystinuria patients. [...]

Cystinuria drugs in development, 2024 Original Story The Cystinuria drugs in development market research report provides comprehensive information on the therapeutics under development for Cystinuria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs [...]

Cable jointers ascend Snowdon to raise £2K for children’s hospital London News Online Original Story  Cable jointers ascend Snowdon to raise £2K for children’s hospital 31 July 2024Claudia Lee Nine cable jointers and craft attendants from UK Power Networks ascended Mount Snowdon in a bid to raise funds for a children’s hospital. The group raised [...]

HÜDA PAR submits parliamentary question on cystinuria medication supply HÜDA PAR Batman MP Serkan Ramanlı has submitted a parliamentary question to the Grand National Assembly of Turkey, addressing the difficulties cystinuria patients face in obtaining essential medication. In a formal question submitted to the Parliament Speaker’s Office, Ramanlı requested Health Minister Kemal Memişoğlu to provide [...]

Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC® MALVERN, Pa. , July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC ® . "We're proud to provide high-quality, affordable choices to healthcare providers and their appropriate patients," said Scott [...]

The antioxidant l-Ergothioneine prevents cystine lithiasis in the Slc7a9−/− mouse model of cystinuria Abstract The high recurrence rate of cystine lithiasis observed in cystinuria patients highlights the need for new therapeutic options to address this chronic disease. There is growing evidence of an antioxidant defect in cystinuria, which has led to test antioxidant molecules as new therapeutic [...]

New tiopronin delayed-release tablets launch with patient support for the treatment of cystinuria in the US Read Full Story BOSTON, May 13, 2024--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) is pleased to announce the launch of tiopronin delayed-release tablets as a treatment option for patients with cystinuria.1 Tiopronin delayed-release tablets are available in 100 mg and 300 mg [...]

Kids and their battles with kidney stones Ivanhoe Newswire - Apr 28, 2024 - SEE ORIGINAL STORY When you think of kidney stones, you may think of middle-aged men. But that's changed dramatically over the last 20 years. More women are now experiencing them. 11% of Americans will have a kidney stone at some point. [...]

FDA grants orphan drug designation to ADV7103 for cystinuria Read Original Story Here The FDA has granted an orphan drug designation (ODD) to ADV7103 for the treatment of patients with cystinuria, according to a news release from Advicenne, the developer of the therapy.1 ADV7103 was also granted an ODD status by the FDA in [...]